Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke.

"Declarations Ethics approval and consent to participateUK Biobank received ethical approval from the Northwest Multicenter Research Ethics Committee. The UK Biobank data are available to researchers after acceptance of the research proposal to the UK Biobank. Written informed consent was obtained from all the participants during recruitment. This study was approved by the Institutional Review Board of Yonsei University Health System (4-2023-0323). Consent for publicationNot applicable. Competing interestsBJ has served as a speaker for Bayer, BMS/Pfizer, Medtronic, and Daiichi-Sankyo and has received research funds from Medtronic and Abbott. BJ received no fees, either directly or personally. The remaining authors have no other relationships or activities that could have influenced the submitted work. Competing interests BJ has served as a speaker for Bayer, BMS/Pfizer, Medtronic, and Daiichi-Sankyo and has received research funds from Medtronic and Abbott. BJ received no fees, either directly or personally. The remaining authors have no other relationships or activities that could have influenced the submitted work."

"Funding This research was supported by a grant from the Patient-Centered Clinical Research Coordinating Centre (PACEN) funded by the Ministry of Health & Welfare, Republic of Korea (HC19C0130). The funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication."